Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Todd Broder

Psychiatry St Augustine, FL Medical Doctor

NPI 1699849349 CMS profile 31068

400 Health Park Blvd, St Augustine, FL 32086

Open in the dashboard

General payments

$1,588,618

2,341 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$103,998 paid to institutions, not to them · program years 2022–2025

Through program year 2025, Todd Broder of St Augustine, FL is reported in the CMS Open Payments database as having received $1,588,618 across 2,341 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $103,998 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $422,655 478
2024 General $419,231 565
2023 General $324,664 434
2022 General $202,286 366
2021 General $68,206 125
2020 General $48,896 117
2019 General $102,681 256

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Todd Broder
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Todd Broder were reported at $422,655. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Todd Broder Psychiatry median Middle half National median
2019 $102,681 $184 $59–$605 $163
2020 $48,896 $119 $36–$372 $114
2021 $68,206 $143 $43–$576 $132
2022 $202,286 $153 $50–$590 $149
2023 $324,664 $170 $56–$651 $160
2024 $419,231 $179 $57–$673 $164
2025 $422,655 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Otsuka America Pharmaceutical, Inc. $396,512 721 payments
  2. Janssen Pharmaceuticals, Inc $395,824 590 payments
  3. Axsome Therapeutics, Inc. $341,914 443 payments
  4. AbbVie, Inc. $216,754 259 payments
  5. E.R. Squibb & Sons, L.L.C. $123,764 139 payments
  6. Alkermes, Inc. $61,627 107 payments
  7. H. Lundbeck A S $46,277 22 payments
  8. Otsuka Pharmaceutical Development & Commercialization, Inc. $2,439 9 payments
  9. Neuronetics, Inc. $1,376 5 payments
  10. LivaNova USA, Inc. $684 11 payments
  11. Other $1,447 35 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $969,677 400 payments
  2. Travel and Lodging $216,342 916 payments
  3. Consulting Fee $209,411 80 payments
  4. Honoraria $147,068 36 payments
  5. Food and Beverage $46,055 905 payments
  6. Education $66 4 payments
Products named General payments · program years 2019–2025
  1. ABILIFY MAINTENA $419,932 695 payments
  2. SPRAVATO $395,747 582 payments
  3. Auvelity $341,914 443 payments
  4. VRAYLAR Neuroscience $149,746 189 payments
  5. ABILIFY ASIMTUFII $118,480 169 payments
  6. COBENFY $92,169 98 payments
  7. VRAYLAR Neuroscience $67,089 71 payments
  8. LYBALVI Cns $60,555 82 payments
  9. LYBALVI Cns $60,253 78 payments
  10. LYBALVI Cns $60,124 74 payments
  11. Other $112,938 377 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 8 billing codes

Paid by Medicare

$21,068

Medicare's payments for the services billed

Medicare patients

64

Average age 65

Services billed

267

34 women, 30 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Depression 67%
Arthritis 47%
Diabetes 39%
COPD 39%
Ischemic heart disease 33%
Chronic kidney disease 28%
Heart failure 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 13 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Auvelity
$146,513 — —
SPRAVATO
$78,146 — —
VRAYLAR
$68,154 — —
ABILIFY MAINTENA
$57,280 — —
ABILIFY ASIMTUFII
$33,571 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 13 in the dashboard with a free account

Records

2,341 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record